Profil
Keith Barclay currently works at Caledonian Holdings Plc, as Investment Director from 2025.
Mr. Barclay also formerly worked at Elasmogen Ltd., as Director & Investor Director and Business Growth Fund Ltd, as Senior Investor from 2015 to 2024.
Mr. Barclay received his graduate degree from the University of Aberdeen.
Aktive Positionen von Keith Barclay
| Unternehmen | Position | Beginn |
|---|---|---|
| CALEDONIAN HOLDINGS PLC | Chief Investment Officer | 01.08.2025 |
Ehemalige bekannte Positionen von Keith Barclay
| Unternehmen | Position | Ende |
|---|---|---|
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Invests in companies located in the United Kingdom and Ireland. The firm targets companies operating in the fields of acquisitions, internationalisation, technology, data and AI sectors. It provides financing for growth and early stage capital requirement with an investment size of GBP 3 - 30 million. It act as a minority investor and makes follow-on investments. | Private Equity Investor | 01.01.2024 |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Develops soloMER products for treatment of auto-immune mediated and inflammatory diseases | Chief Investment Officer | - |
Ausbildung von Keith Barclay
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Vela Technologies Plc
Vela Technologies Plc Financial ConglomeratesFinance Operates as an investment company | Finance |
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Invests in companies located in the United Kingdom and Ireland. The firm targets companies operating in the fields of acquisitions, internationalisation, technology, data and AI sectors. It provides financing for growth and early stage capital requirement with an investment size of GBP 3 - 30 million. It act as a minority investor and makes follow-on investments. | Finance |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Develops soloMER products for treatment of auto-immune mediated and inflammatory diseases | Health Technology |
















